The antitumor activity of doxorubicin against drug-resistant murine carcinoma is enhanced by oral administration of a synthetic staurosporine analogue, CGP 41251. (Q41383721)
Jump to navigation
Jump to search
scientific article published on January 1995
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The antitumor activity of doxorubicin against drug-resistant murine carcinoma is enhanced by oral administration of a synthetic staurosporine analogue, CGP 41251. |
scientific article published on January 1995 |
Statements
The antitumor activity of doxorubicin against drug-resistant murine carcinoma is enhanced by oral administration of a synthetic staurosporine analogue, CGP 41251 (English)
J J Killion
P Beltran
C A O'Brian
S S Yoon
D Fan
1 January 1995